UDG Healthcare has reported earnings per share at the top end of analyst expectations in its full year results.
Earnings per share of 48.4 cents represented growth of 7%.
Analysts had been guiding growth of around 5-7%.
The group reported operating profit of $158.4 million, which was up 9% on a constant currency basis.
It's proposing a final dividend of 12.34 cents per share, representing a 5% increase.
"2019 was another year of strong strategic progress for UDG Healthcare. We delivered good financial growth with adjusted earnings per share increasing by 7% on a constant currency basis, the top end of guidance," Brendan McAtamney, chief executive of UDG said.
"Our two global platforms, Ashfield and Sharp delivered a strong performance through a combination of underlying growth and the benefit of acquisitions," he added.
The Group completed three acquisitions to date in 2019 spending up to $137 million.
It also announced the acquisition of US strategic scientific communications agency, Canale Communications.
"All three acquisitions are in line with our strategy to expand into higher growth and higher margin areas, complementary to our existing service offering," Mr McAtamney added.
"Looking ahead to FY20, we expect to continue to deliver good growth across our businesses, supplemented by further strategic acquisitions utilising our strong balance sheet."